Business Context and Reporting Period
This Form 10-Q, filed November 14, 2023, covers the quarter ended September 30, 2023. The filing registrant is Inflection Point Acquisition Corp. II, not USA Rare Earth, Inc.; the source text does not explain the metadata discrepancy.
The registrant is a Cayman Islands special purpose acquisition company formed on March 6, 2023. It had not commenced operating activities or selected a business-combination target as of September 30, 2023. Its activities consisted of formation, the May 30, 2023 initial public offering, and searching for a target.
Key Financial Metrics
| Metric | Three months ended September 30, 2023 | Inception through September 30, 2023 |
|---|---|---|
| Operating revenue | $0 | $0 |
| Formation and operating costs | $420,837 | $655,690 |
| Interest income from Trust Account | $3,270,011 | $4,329,480 |
| Net income | $2,856,883 | $3,681,499 |
| Net cash used in operating activities | Not separately presented | $811,083 |
| Cash | $337,588 at September 30 | $337,588 at September 30 |
| Trust Account investments | $255,579,480 at September 30 | $255,579,480 at September 30 |
| Total liabilities | $13,297,693 at September 30 | $13,297,693 at September 30 |
Net income was generated almost entirely by interest on Trust Account investments and bank deposits, rather than operating activity. Operating margins are not meaningful because the company has no operating revenue. The filing does not provide a meaningful prior comparable-period analysis because the company was formed in March 2023 and had no prior-year comparable quarter.
Cash flow included $251.25 million invested in the Trust Account and $252.4 million of net financing cash inflows, principally IPO and private-placement proceeds. The company had no long-term debt or capital leases. A $13.1 million deferred underwriting fee is payable upon completion of a business combination, subject to the underwriting agreement.
Material Changes and Unusual Items
- On May 30, 2023, the company sold 25 million units at $10.00 per unit, generating $250 million of gross proceeds, including 3 million units issued through a partial over-allotment exercise.
- The company sold 7.65 million private-placement warrants for $7.65 million. Total warrants outstanding were 20.15 million, each generally exercisable at $11.50 per share after a business combination.
- Of total IPO-related transaction costs of $18.36 million, $4.4 million was paid in cash, $13.1 million was deferred, and $861,877 represented other offering costs.
- The 25 million public shares are classified as temporary equity and carried at a redemption value of $255.58 million, or approximately $10.22 per share.
- The Sponsor held 6.25 million founder shares after 75,000 shares were forfeited following the partial over-allotment exercise.
- The company incurred $81,250 in quarterly fees, and $115,555 cumulatively, under a services agreement with The Venture Collective LLC, an affiliate of a director. The agreement requires aggregate monthly payments of $27,083.33 until a business combination or liquidation.
Outlook, Risks, Contingencies, and Management Commentary
Management intends to use substantially all Trust Account funds, less deferred underwriting commissions and taxes, to complete an initial business combination. The completion window is 18 months from the IPO closing, or by approximately November 30, 2024, unless an earlier liquidation date is approved. If no transaction is completed, public shares are expected to be redeemed, subject to applicable law and creditor claims.
Management disclosed substantial doubt about the company’s ability to continue as a going concern because only $337,588 was held outside the Trust Account while the company expects to continue incurring acquisition and public-company costs. Additional Sponsor or other financing may be needed, but such financing is not committed.
- There is no assurance that a business combination will be identified or completed within the completion window.
- Public shareholder redemptions could reduce funds available to the post-combination company and may require additional financing, equity issuance, or debt.
- Trust Account assets may be subject to creditor claims, and the Sponsor’s indemnification capacity has not been independently verified.
- The company may incur additional working-capital loans of up to $1.5 million that could be convertible into private-placement warrants; none were outstanding at September 30, 2023.
- The filing identifies continuing uncertainty from broader economic conditions, the COVID-19 pandemic, and the Russia-Ukraine conflict, although specific effects were not determinable.
- No legal proceedings, material changes to previously disclosed risk factors, or off-balance-sheet arrangements were reported.
- Management concluded that disclosure controls and procedures were effective at a reasonable assurance level, with no material changes in internal control over financial reporting.
Investor Verification Checklist
- Verify the registrant’s identity and whether this filing is relevant to USA Rare Earth, Inc.; the filing itself is for Inflection Point Acquisition Corp. II.
- Confirm the status of any business-combination target, transaction negotiations, and the applicable completion or liquidation deadline.
- Reconcile the $255.58 million Trust Account balance, the $13.1 million deferred underwriting fee, and the per-share redemption value.
- Assess whether the $337,588 of unrestricted cash is sufficient for expenses through the completion window or whether additional financing is required.
- Review potential dilution from 6.25 million founder shares and 20.15 million warrants.
- Evaluate related-party service payments, potential working-capital loans, Sponsor indemnification capacity, and creditor claims against Trust Account assets.
- Review subsequent SEC filings for redemptions, extensions, a business-combination announcement, liquidation, or changes to the going-concern assessment.